Conduit Pharmaceuticals Inc. has announced a strategic services agreement with Agility Life Sciences to develop new solid oral-dosage form products for its autoimmune pipeline, intended for future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback